{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:28Z","timestamp":1785894808121,"version":"3.56.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/356\/46"],"award-info":[{"award-number":["RGP2\/356\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpet.2026.104954","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:14:56Z","timestamp":1780067696000},"page":"104954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanomedicine strategies targeting STAT3 in cancer: From tumor suppression to microenvironment modulation"],"prefix":"10.1016","volume":"393","author":[{"given":"Zouaouia","family":"Chama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam Yaseen","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareshkumar N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4146-6101","authenticated-orcid":false,"given":"Mirza R.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Saeed","family":"Basunduwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun Signal"},{"issue":"13","key":"10.1016\/j.jpet.2026.104954_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2174\/0113895575254012231024062619","article-title":"Targeting STAT3 Enzyme for Cancer treatment","volume":"24","author":"Arun","year":"2024","journal-title":"Mini Rev Med Chem"},{"issue":"10","key":"10.1016\/j.jpet.2026.104954_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41419-023-06148-6","article-title":"PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jpet.2026.104954_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110275","article-title":"Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions","volume":"92","author":"El-Tanani","year":"2022","journal-title":"Cell Signal"},{"key":"10.1016\/j.jpet.2026.104954_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173107","article-title":"Targeting STAT3 in cancer and autoimmune diseases","volume":"878","author":"Gharibi","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104954_bib7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s11596-022-2655-8","article-title":"TRIB3 interacts with STAT3 to promote cancer angiogenesis","volume":"42","author":"Chen","year":"2022","journal-title":"Curr Med Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12964-024-01550-9","article-title":"CD146(+)CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10\/JAK1\/STAT3 pathway","volume":"22","author":"Yu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jpet.2026.104954_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106311","article-title":"STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response","volume":"182","author":"Sadrkhanloo","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jpet.2026.104954_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114168","article-title":"STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions","volume":"158","author":"Sadrkhanloo","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jpet.2026.104954_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2022.10.023","article-title":"Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis","volume":"352","author":"Pei","year":"2022","journal-title":"J Control Release"},{"issue":"13","key":"10.1016\/j.jpet.2026.104954_bib14","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/molecules28135145","article-title":"Cancer nanomedicine: emerging strategies and therapeutic potentials","volume":"28","author":"Xu","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41571-022-00717-y","article-title":"Thermal immuno-nanomedicine in cancer","volume":"20","author":"Yang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104954_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","article-title":"Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects","volume":"4","author":"Zhang","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.jpet.2026.104954_bib17","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.7150\/thno.87854","article-title":"Stimuli-activatable nanomedicine meets cancer theranostics","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.jpet.2026.104954_bib18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41401-020-0448-9","article-title":"Cancer nanomedicine meets immunotherapy: opportunities and challenges","volume":"41","author":"Sun","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jpet.2026.104954_bib19","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2147\/IJN.S362244","article-title":"Cucumber-derived nanovesicles containing cucurbitacin B for non-small cell lung cancer therapy","volume":"17","author":"Chen","year":"2022","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"10.1016\/j.jpet.2026.104954_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/CAD.0000000000001461","article-title":"STAT3 shRNA delivery with folate receptor-modified multi-functionalized graphene oxide particles for combined infrared radiation and gene therapy in hepatocellular carcinoma","volume":"34","author":"Chen","year":"2023","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/biom10020285","article-title":"Silencing of STAT3 via peptidomimetic lnp-mediated systemic delivery of RNAi downregulates PD-L1 and inhibits melanoma growth","volume":"10","author":"Ehexige","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2026.104954_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114918","article-title":"ATB(0,+)-targeted nanoparticles trigger STAT3-ferroptosis regulatory axis for enhanced gastric cancer therapy","volume":"255","author":"Zheng","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jpet.2026.104954_bib23","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S398046","article-title":"Resveratrol loaded by folate-nodified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2\/STAT3 pathway","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"10.1016\/j.jpet.2026.104954_bib24","first-page":"1591","article-title":"In vitro study of a siRNA delivery liposome constructed with an ionizable cationic lipid","volume":"49","author":"Hu","year":"2024","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/1061186X.2016.1258567","article-title":"Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer","volume":"25","author":"Jose","year":"2017","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2017.04.034","article-title":"Preparation and characterization of lipid nanoparticle\/pDNA complexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells","volume":"525","author":"Kotmak\u00e7\u0131","year":"2017","journal-title":"Int J Pharm"},{"issue":"Pt 2","key":"10.1016\/j.jpet.2026.104954_bib27","article-title":"Biomimetic anlotinib-loaded FePc-silicate nanoparticles for sonodynamic and immunotherapy in non-small cell lung cancer via dual PD-L1 modulation","volume":"256","author":"Liu","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jpet.2026.104954_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.envpol.2016.04.072","article-title":"Atmospheric particulate matter (PM10) exposure-induced cell cycle arrest and apoptosis evasion through STAT3 activation via PKC\u03b6 and Src kinases in lung cells","volume":"214","author":"Reyes-Z\u00e1rate","year":"2016","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jpet.2026.104954_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137751","article-title":"Brain-targeted polymersomes mediating RNAi of STAT3 sensitize glioblastoma to temozolomide and immunotherapy","volume":"695","author":"Xia","year":"2025","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.jpet.2026.104954_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111109","article-title":"Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition","volume":"193","author":"Zheng","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"10.1016\/j.jpet.2026.104954_bib31","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/cancers17101648","article-title":"Exosome enveloped by nano lipid particle a new model for signal transducer and activator of transcription 3 silencer ribonucleic acid delivery system to a glioblastoma mice model","volume":"17","author":"Monfaredan","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib32","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/jat.4196","article-title":"Exposure interval to ambient fine particulate matter (PM2.5) collected in Southwest China induced pulmonary damage through the Janus tyrosine protein kinase-2\/signal transducer and activator of transcription-3 signaling pathway both in vivo and in vitro","volume":"41","author":"Yue","year":"2021","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jpet.2026.104954_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767939","article-title":"Exploiting the STAT3 nexus in cancer-associated fibroblasts to improve cancer therapy","volume":"12","author":"Allam","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2024.195051","article-title":"Crosstalk between circular RNAs and the STAT3 signaling pathway in human cancer","volume":"1867","author":"Almouh","year":"2024","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.jpet.2026.104954_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70045","article-title":"The role of STAT3 in cancer: from metabolic regulation to therapeutic targeting","author":"Ashourpour","year":"2025","journal-title":"Biofactors"},{"key":"10.1016\/j.jpet.2026.104954_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118999","article-title":"Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer","volume":"268","author":"Aziz","year":"2021","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.jpet.2026.104954_bib37","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: a review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpet.2026.104954_bib38","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2015.14215","article-title":"IL-6\/STAT3\/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer","volume":"145","author":"Pencik","year":"2015","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpet.2026.104954_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155810","article-title":"STAT3-related lncRNAs in colorectal cancer progression; Special focus on immune cell's evasion","volume":"266","author":"Saadh","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13046-019-1091-5","article-title":"A novel miR-365-3p\/EHF\/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing \u03b25-integrin\/c-met signaling pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpet.2026.104954_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2020.02.026","article-title":"Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer","volume":"476","author":"Qin","year":"2020","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","article-title":"Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis","volume":"39","author":"Guccini","year":"2021","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.jpet.2026.104954_bib45","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/cells9102202","article-title":"Perspectives regarding the intersections between STAT3 and oxidative metabolism in cancer","volume":"9","author":"Chun","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jpet.2026.104954_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2016.06.034","article-title":"STAT3 in prostate cancer: whom should we treat and when?","volume":"71","author":"Culig","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpet.2026.104954_bib47","article-title":"The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104954_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70829","article-title":"Curcumin and resveratrol as dual modulators of the STAT3 pathway in lung cancer: a comprehensive review","volume":"13","author":"Zamanian","year":"2025","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jpet.2026.104954_bib49","article-title":"Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2024.195028","article-title":"The essential link: How STAT3 connects tumor metabolism to immunity","volume":"1867","author":"Zhong","year":"2024","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.jpet.2026.104954_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.jpet.2026.104954_bib53","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/ijms19061803","article-title":"STAT3 in tumor-associated myeloid cells: multitasking to disrupt immunity","volume":"19","author":"Su","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104954_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jpet.2026.104954_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215880","article-title":"Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity","volume":"547","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.jpet.2026.104954_bib56","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.3390\/ijms24054722","article-title":"Overcoming acquired drug resistance to cancer therapies through targeted STAT3 inhibition","volume":"24","author":"Singh","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tips.2015.10.001","article-title":"Feedback activation of STAT3 as a cancer drug-resistance mechanism","volume":"37","author":"Zhao","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"20","key":"10.1016\/j.jpet.2026.104954_bib58","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpet.2026.104954_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib60","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.immuni.2021.11.004","article-title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1(int) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity","volume":"54","author":"Hanna","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jpet.2026.104954_bib61","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","article-title":"Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma","volume":"39","author":"Hara","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpet.2026.104954_bib62","article-title":"Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages","volume":"2024","author":"Lee","year":"2025","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib64","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.3390\/pharmaceutics14122787","article-title":"Nanoparticle-mediated delivery of STAT3 inhibitors in the treatment of lung cancer","volume":"14","author":"Feng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2026.104954_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/acs.bioconjchem.4c00379","article-title":"Suppressing pancreatic cancer survival and immune escape via nanoparticle-modulated STING\/STAT3 axis regulation","volume":"35","author":"Li","year":"2024","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jpet.2026.104954_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121526","article-title":"Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer","volume":"616","author":"Singh","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jpet.2026.104954_bib67","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.2147\/IJN.S277845","article-title":"Treatment of colon cancer by degradable rrPPC nano-conjugates delivered STAT3 siRNA","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-024-13401-4","article-title":"Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2\/STAT3\/mTOR\/PI3K pathway","volume":"25","author":"YektaKooshali","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpet.2026.104954_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.jpet.2026.104954_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2024.10.004","article-title":"Brain targeted biomimetic siRNA nanoparticles for drug resistance glioblastoma treatment","volume":"376","author":"Li","year":"2024","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ntno.22335","article-title":"Dual radiosensitization and anti-STAT3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells","volume":"2","author":"Zhang","year":"2018","journal-title":"Nanotheranostics"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijpharm.2017.03.087","article-title":"Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles","volume":"525","author":"Labala","year":"2017","journal-title":"Int J Pharm"},{"issue":"29","key":"10.1016\/j.jpet.2026.104954_bib73","article-title":"A pH-Sensitive Nanosized Covalent-Organic Polymer for Enhanced Tumor Photodynamic Immunotherapy by Hypoxia Relief and STAT3 Inhibition","volume":"12","author":"Lei","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib74","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/1535-7163.MCT-20-0505","article-title":"Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles","volume":"20","author":"To\u0161i\u0107","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/mmr.2017.6583","article-title":"Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle-delivered short hairpin RNAs against Stat3","volume":"16","author":"Liang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"13","key":"10.1016\/j.jpet.2026.104954_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404737","article-title":"Dual-mode radiosensitization of esophageal squamous cell carcinoma via SOCS6-loaded virus-inspired manganese-bismuth bimetallic oxide nanoparticles","volume":"14","author":"Ma","year":"2025","journal-title":"Adv Healthc Mater"},{"issue":"13","key":"10.1016\/j.jpet.2026.104954_bib77","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2026.104954_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116765","article-title":"Isoalantolactone\/hydroxamic acid hybrids as potent dual STAT3\/HDAC inhibitors and self-assembled nanoparticles for cancer therapy","volume":"277","author":"Mo","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2026.104954_bib79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.actbio.2021.07.029","article-title":"Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer","volume":"134","author":"Luo","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jpet.2026.104954_bib80","first-page":"137","article-title":"STAT3-specific nanocarrier for shRNA\/drug dual delivery and tumor synergistic therapy","volume":"41","author":"Sun","year":"2024","journal-title":"Bioact Mater"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib81","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1186\/s12967-024-05917-x","article-title":"Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages","volume":"22","author":"Song","year":"2024","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.jpet.2026.104954_bib82","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/cancers11030333","article-title":"Therapeutic targeting of Stat3 using lipopolyplex nanoparticle-formulated siRNA in a syngeneic orthotopic mouse glioma model","volume":"11","author":"Linder","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40360-022-00589-z","article-title":"A novel nitidine chloride nanoparticle overcomes the stemness of CD133+ EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapy","volume":"23","author":"Li","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"issue":"35","key":"10.1016\/j.jpet.2026.104954_bib84","doi-asserted-by":"crossref","first-page":"27429","DOI":"10.1074\/jbc.M110.142752","article-title":"Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells","volume":"285","author":"Liu","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.jpet.2026.104954_bib85","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.6b01119","article-title":"Self-associating poly(ethylene oxide)-block-poly(\u03b1-carboxyl-\u03b5-caprolactone) drug conjugates for the delivery of STAT3 inhibitor JSI-124: potential application in cancer immunotherapy","volume":"14","author":"Garg","year":"2017","journal-title":"Mol Pharm"},{"issue":"42","key":"10.1016\/j.jpet.2026.104954_bib86","doi-asserted-by":"crossref","first-page":"28764","DOI":"10.1021\/acsnano.4c07903","article-title":"Harnessing the power of sugar-based nanoparticles: a drug-free approach to enhance immune checkpoint inhibition against glioblastoma and pancreatic cancer","volume":"18","author":"Hsu","year":"2024","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.jpet.2026.104954_bib87","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3390\/cancers15235647","article-title":"Oligonucleotide-based therapeutics for STAT3 targeting in cancer\u2014drug carriers matter","volume":"15","author":"Molenda","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jpet.2026.104954_bib88","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41401-024-01261-4","article-title":"Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma","volume":"45","author":"Zhang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jpet.2026.104954_bib89","article-title":"Targeted S100A8 PP-Cas9@PLGA-apt microparticles reduced cartilage degradation and subchondral bone isomerism in osteoarthritis treatment through JAK\/STAT3 pathway modulation","volume":"35","author":"Chen","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.jpet.2026.104954_bib90","first-page":"1648","article-title":"Engineering pH-Responsive Dendrimer-STAT3 Inhibitor Conjugates for Intracellular Delivery","volume":"2026","author":"Siva Sankara","year":"2026","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib91","first-page":"459","article-title":"[Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer]","volume":"27","author":"Zhao","year":"2007","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"10","key":"10.1016\/j.jpet.2026.104954_bib92","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.4049\/jimmunol.1600833","article-title":"4PD functionalized dendrimers: a flexible tool for in vivo gene silencing of tumor-educated myeloid cells","volume":"198","author":"Zilio","year":"2017","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.jpet.2026.104954_bib93","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1039\/D1TB00029B","article-title":"A hybrid membrane coating nanodrug system against gastric cancer via the VEGFR2\/STAT3 signaling pathway","volume":"9","author":"Long","year":"2021","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.jpet.2026.104954_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.625084","article-title":"Dual targeting EGFR and STAT3 with erlotinib and alantolactone co-loaded PLGA nanoparticles for pancreatic cancer treatment","volume":"12","author":"Bao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib95","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00210-023-02612-4","article-title":"Ligand-based active targeting strategies for cancer theranostics","volume":"396","author":"Bandyopadhyay","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib96","article-title":"Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: a STAT3 signaling pathway modulation approach","volume":"20","author":"Wu","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.jpet.2026.104954_bib97","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/IJN.S346685","article-title":"Hybrid cell membrane-functionalized biomimetic nanoparticles for targeted therapy of osteosarcoma","volume":"17","author":"Cai","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jpet.2026.104954_bib98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2023.09.044","article-title":"A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3","volume":"363","author":"Feng","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib99","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12951-021-01125-7","article-title":"Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy","volume":"19","author":"Bu","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jpet.2026.104954_bib100","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.2147\/IJN.S248667","article-title":"Nanoparticle BAF312@ CaP-NP overcomes sphingosine-1-phosphate receptor-1-mediated chemoresistance through inhibiting S1PR1\/P-STAT3 axis in ovarian carcinoma","volume":"15","author":"Gong","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib101","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12964-024-01841-1","article-title":"STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation","volume":"22","author":"Lee","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.jpet.2026.104954_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008491","article-title":"Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model","volume":"12","author":"Sun","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib104","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7150\/thno.65411","article-title":"HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jpet.2026.104954_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109568","article-title":"Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6\/JAK2\/STAT3 signaling axis","volume":"125","author":"Pradhan","year":"2024","journal-title":"J Nut Biochem"},{"issue":"4","key":"10.1016\/j.jpet.2026.104954_bib107","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1021\/acsabm.5c00002","article-title":"Glucocorticoid receptor-targeted nanoliposome for STAT3 inhibition-led myeloid-derived suppressor cell modulation and efficient colon cancer treatment","volume":"8","author":"Bhattacharyya","year":"2025","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12951-021-00904-6","article-title":"The targetable nanoparticle BAF312@ cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1\/P-STAT3\/VEGFA axis in triple-negative breast cancer","volume":"19","author":"Gong","year":"2021","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib109","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","article-title":"JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases","volume":"25","author":"Dai","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib110","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2527752","article-title":"Nanomedicine initiates ferroptosis for enhanced lung cancer therapy","volume":"32","author":"Xu","year":"2025","journal-title":"Drug Deliv"},{"issue":"32","key":"10.1016\/j.jpet.2026.104954_bib111","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.1021\/acsnano.4c05084","article-title":"Biomineralization-tuned nanounits reprogram the signal transducer and activator of transcription 3 signaling for ferroptosis-immunotherapy in cancer stem cells","volume":"18","author":"Zhao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpet.2026.104954_bib112","article-title":"Nanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors","author":"Ye","year":"2026","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib113","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/biomedicines14010228","article-title":"The mechanism and regulation of disulfidptosis and its role in disease","volume":"14","author":"Wan","year":"2026","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.jpet.2026.104954_bib114","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Inhibition of endoplasmic reticulum stress cooperates with SLC7A11 to promote disulfidptosis and suppress tumor growth upon glucose limitation","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jpet.2026.104954_bib115","doi-asserted-by":"crossref","first-page":"12639","DOI":"10.1002\/cam4.5954","article-title":"Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3","volume":"12","author":"Gu","year":"2023","journal-title":"Cancer Med"},{"issue":"23","key":"10.1016\/j.jpet.2026.104954_bib116","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1021\/acsnano.5c04036","article-title":"Virus-like nanoparticles deliver small interfering RNA to pancreatic cancer cells through filopodia-mediated internalization","volume":"19","author":"Yi","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpet.2026.104954_bib117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2020.01.044","article-title":"Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3\/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes","volume":"320","author":"Chen","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2026.104954_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124689","article-title":"Intestinal probiotic-based nanoparticles for cytotoxic siRNA delivery in immunotherapy against cancer","volume":"665","author":"Zhu","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jpet.2026.104954_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122573","article-title":"A novel combination for the treatment of small cell lung cancer: active targeted irinotecan and stattic co-loaded PLGA nanoparticles","volume":"632","author":"Arslan","year":"2023","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.ymthe.2019.08.008","article-title":"Increased survival by pulmonary treatment of established lung metastases with dual STAT3\/CXCR4 inhibition by siRNA nanoemulsions","volume":"27","author":"Li","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jpet.2026.104954_bib121","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S337093","article-title":"Chitosan-coated-PLGA nanoparticles enhance the antitumor and antimigration activity of stattic - a STAT3 dimerization blocker","author":"Fong","year":"2022","journal-title":"Int J Nanomed"},{"issue":"3","key":"10.1016\/j.jpet.2026.104954_bib122","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.nano.2017.12.020","article-title":"Nanoliposomal delivery of cytosolic phospholipase A(2) inhibitor arachidonyl trimethyl ketone for melanoma treatment","volume":"14","author":"Gowda","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jpet.2026.104954_bib123","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/cancers11020248","article-title":"Decoration of anti-CD38 on nanoparticles carrying a STAT3 inhibitor can improve the therapeutic efficacy against myeloma","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.29252\/ibj.23.1.21","article-title":"Anti-mucin1 aptamer-conjugated chitosan nanoparticles for targeted co-delivery of docetaxel and IGF-1R siRNA to SKBR3 metastatic breast cancer cells","volume":"23","author":"Jafari","year":"2019","journal-title":"Iran Biomed J"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11033-025-10835-2","article-title":"Curcumin and Silibinin loaded pegylated nanoniosome for cancer therapy: bioinformatics and in vitro study","volume":"52","author":"Hooshiar","year":"2025","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10.1016\/j.jpet.2026.104954_bib126","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/pharmaceutics17070945","article-title":"Dual-action tocilizumab-conjugated cisplatin nanoparticles overcome chemoresistance and metastasis in non-small-cell lung cancer","volume":"17","author":"Wang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2026.104954_bib127","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.001","article-title":"Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy","volume":"325","author":"Shobaki","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.jpet.2026.104954_bib128","article-title":"Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors","volume":"145","author":"Tang","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.jpet.2026.104954_bib129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.omto.2021.12.025","article-title":"Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells","volume":"24","author":"Lv","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"12","key":"10.1016\/j.jpet.2026.104954_bib130","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/03639045.2025.2564364","article-title":"Advances in novel drug delivery systems: a focus on nanoparticles and mucoadhesive technologies","volume":"51","author":"Sangavi","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jpet.2026.104954_bib131","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002355","article-title":"Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response","volume":"6","author":"Singh","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104954_bib132","first-page":"31","article-title":"Nanoparticle-based therapeutic strategies in respiratory diseases: current approaches and future prspectives","volume":"26","author":"Cinar","year":"2025","journal-title":"Thorac Res Pract"},{"key":"10.1016\/j.jpet.2026.104954_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117499","article-title":"Silencing of p68 and STAT3 synergistically diminishes cancer progression","volume":"249","author":"Hashemi","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104954_bib134","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tplants.2023.11.024","article-title":"Next generation chemical priming: with a little help from our nanocarrier friends","volume":"29","author":"Gohari","year":"2024","journal-title":"Trends Plant Sci"},{"issue":"46","key":"10.1016\/j.jpet.2026.104954_bib135","doi-asserted-by":"crossref","first-page":"63213","DOI":"10.1021\/acsami.5c18158","article-title":"Targeted dual-modality imaging of inflammation using 18F-radiolabeled iron oxide microparticles","volume":"17","author":"Guillou","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/j.jpet.2026.104954_bib136","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2519823123","article-title":"Fluorinated lipid nanoparticles enable real-time tracking of mRNA delivery and uncover spatiotemporal mechanisms of immune activation","volume":"123","author":"Xie","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2026.104954_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115946","article-title":"Advances in targeted therapeutics and smart delivery systems based on precision nano-oncology","volume":"169","author":"Ma","year":"2026","journal-title":"Int Immunopharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:31:58Z","timestamp":1785893518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":137,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022356526011535"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104954","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine strategies targeting STAT3 in cancer: From tumor suppression to microenvironment modulation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104954"}}